BACKGROUND: There is preliminary evidence that repetitive transcranial magnetic stimulation (rTMS) may be useful in obsessive-compulsive disorder (OCD) patients. METHODS: Our objective was to examine efficacy of adjunctive right prefrontal high-frequency (rapid) rTMS treatment in OCD patients. 42 patients with OCD were randomly assigned to 10 sessions of add-on high-frequency right prefrontal active rTMS (10Hz, 110% of motor threshold, 4s per train, 20 trains per session) or sham stimulation. They were rated on Yale Brown Obsessive Compulsive Scale (YBOCS), Hamilton Rating Scale for Depression (HAM-D), Hamilton Rating Scale for Anxiety (HAM-A) and Clinical Global Impression-Severity of Illness (CGI-S) at baseline, day 14 and day 28. The dose of antiobsessive drug was kept constant throughout the period of assessment. RESULTS: For YBOCS scores, repeated measures ANOVA showed significant main effect of treatment, but no effect of treatment over time (Pillai's Trace F=1.39, p=.262). However, significant effect of treatment over time as shown by interaction effect for both HAM-D (Pillai's Trace F=3.67, p=.035, eta(2)=.158) and HAM-A scores (Pillai's Trace F=5.22, p=.01, eta(2)=.211) were seen. CONCLUSION: Adjunctive high-frequency right prefrontal rTMS does not have any significant effect in the treatment of OCD. However, it is modestly effective in the treatment of comorbid depressive symptoms in patients with OCD. Copyright 2010 Elsevier Ltd. All rights reserved.
RCT Entities:
BACKGROUND: There is preliminary evidence that repetitive transcranial magnetic stimulation (rTMS) may be useful in obsessive-compulsive disorder (OCD) patients. METHODS: Our objective was to examine efficacy of adjunctive right prefrontal high-frequency (rapid) rTMS treatment in OCDpatients. 42 patients with OCD were randomly assigned to 10 sessions of add-on high-frequency right prefrontal active rTMS (10Hz, 110% of motor threshold, 4s per train, 20 trains per session) or sham stimulation. They were rated on Yale Brown Obsessive Compulsive Scale (YBOCS), Hamilton Rating Scale for Depression (HAM-D), Hamilton Rating Scale for Anxiety (HAM-A) and Clinical Global Impression-Severity of Illness (CGI-S) at baseline, day 14 and day 28. The dose of antiobsessive drug was kept constant throughout the period of assessment. RESULTS: For YBOCS scores, repeated measures ANOVA showed significant main effect of treatment, but no effect of treatment over time (Pillai's Trace F=1.39, p=.262). However, significant effect of treatment over time as shown by interaction effect for both HAM-D (Pillai's Trace F=3.67, p=.035, eta(2)=.158) and HAM-A scores (Pillai's Trace F=5.22, p=.01, eta(2)=.211) were seen. CONCLUSION: Adjunctive high-frequency right prefrontal rTMS does not have any significant effect in the treatment of OCD. However, it is modestly effective in the treatment of comorbid depressive symptoms in patients with OCD. Copyright 2010 Elsevier Ltd. All rights reserved.
Authors: Isidoor O Bergfeld; Eva Dijkstra; Ilse Graat; Pelle de Koning; Bastijn J G van den Boom; Tara Arbab; Nienke Vulink; Damiaan Denys; Ingo Willuhn; Roel J T Mocking Journal: Curr Top Behav Neurosci Date: 2021
Authors: Natasha M Senço; Yu Huang; Giordano D'Urso; Lucas C Parra; Marom Bikson; Antonio Mantovani; Roseli G Shavitt; Marcelo Q Hoexter; Eurípedes C Miguel; André R Brunoni Journal: Expert Rev Med Devices Date: 2015-05-17 Impact factor: 3.166
Authors: Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker Journal: BMC Psychiatry Date: 2014-07-02 Impact factor: 3.630